MedTrace Logo

Virtual Classroom Training and SMS Supported Interventions Improving Foot Care and Self-Efficacy

NCT06213337 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-01-19

No results posted yet for this study

Summary

The type of this research is a randomized controlled experimental study. The aim of the research is to determine the effectiveness of virtual classroom training and SMS support in improving foot care behaviour and foot care self-efficacy in diabetic patients.

The basic questions the research aims to answer are:

* Is virtual classroom training effective in improving foot care behaviour and foot care self-efficacy in diabetic patients?
* Are SMS-supported interventions effective in improving foot care behaviour and foot care self-efficacy in diabetic patients? Within the scope of the research, participants are expected to attend virtual classroom training and read the SMS sentences sent.

In order to examine the effects of virtual classroom training and SMS-supported interventions, researchers created a control group, a virtual classroom, an SMS support group, and an SMS-supported virtual classroom group.

Conditions

  • Diabetic Foot Ulcer

Interventions

OTHER

Foot care training with virtual classroom

Providing foot care training once every two weeks in virtual classes created via the Google meet application.

OTHER

Foot care training with SMS support

Total of 60 SMS messages containing foot care information will be sent, one every day.

OTHER

Foot care training with virtual classroom and SMS support

Providing foot care training once every two weeks in virtual classes created via the Google meet application. Furthermore, total of 60 SMS messages containing foot care information will be sent, one every day.

Sponsors & Collaborators

  • Ondokuz Mayıs University

    lead OTHER

Principal Investigators

  • Burak Arslan, Lecturer · Hitit University

  • Afitap Özdelikara, Assoc. Prof. · Ondokuz Mayıs University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-03-01
Primary Completion
2024-01-31
Completion
2024-04-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06213337 on ClinicalTrials.gov